233 related articles for article (PubMed ID: 12011227)
1. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
Li S; Zhang X; Xia X
J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site.
Li S; Zhang X; Xia X; Zhou L; Breau R; Suen J; Hanna E
Gene Ther; 2001 Mar; 8(5):400-7. PubMed ID: 11313817
[TBL] [Abstract][Full Text] [Related]
3. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.
Li S; Xia X; Mellieon FM; Liu J; Steele S
Mol Ther; 2004 Mar; 9(3):347-54. PubMed ID: 15006601
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site.
Hanna E; Zhang X; Woodlis J; Breau R; Suen J; Li S
Cancer Gene Ther; 2001 Mar; 8(3):151-7. PubMed ID: 11332985
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model.
Imagawa Y; Satake K; Kato Y; Tahara H; Tsukuda M
Auris Nasus Larynx; 2004 Sep; 31(3):239-45. PubMed ID: 15364358
[TBL] [Abstract][Full Text] [Related]
6. Transfection of the genes for interleukin-12 into the K1735 melanoma and the EMT6 mammary sarcoma murine cell lines reveals distinct mechanisms of antitumor activity.
Moran JP; Gerber SA; Martin CA; Frelinger JG; Lord EM
Int J Cancer; 2003 Sep; 106(5):690-8. PubMed ID: 12866028
[TBL] [Abstract][Full Text] [Related]
7. Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination.
Torrero M; Li S
Methods Mol Biol; 2008; 423():339-49. PubMed ID: 18370212
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tumor growth through inhibition of tumor vessel formation.
Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
J Invest Dermatol; 2002 Sep; 119(3):541-8. PubMed ID: 12230493
[TBL] [Abstract][Full Text] [Related]
9. Regression of tumors by IFN-alpha electroporation gene therapy and analysis of the responsible genes by cDNA array.
Li S; Xia X; Zhang X; Suen J
Gene Ther; 2002 Mar; 9(6):390-7. PubMed ID: 11960315
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
[TBL] [Abstract][Full Text] [Related]
11. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
12. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma.
Li D; Shugert E; Guo M; Bishop JS; O'Malley BW
Arch Otolaryngol Head Neck Surg; 2001 Nov; 127(11):1319-24. PubMed ID: 11701067
[TBL] [Abstract][Full Text] [Related]
13. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
14. [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model].
Liu SX; Yang H; Yuan YM; Guo YF; Tang ZQ; Liang CY
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):278-82. PubMed ID: 15338865
[TBL] [Abstract][Full Text] [Related]
15. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
[TBL] [Abstract][Full Text] [Related]
16. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
[TBL] [Abstract][Full Text] [Related]
17. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity.
Palmer K; Hitt M; Emtage PC; Gyorffy S; Gauldie J
Gene Ther; 2001 Feb; 8(4):282-90. PubMed ID: 11313802
[TBL] [Abstract][Full Text] [Related]
18. Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma.
Pavlin D; Cemazar M; Kamensek U; Tozon N; Pogacnik A; Sersa G
Cancer Biol Ther; 2009 Nov; 8(22):2114-22. PubMed ID: 19755854
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H mice.
Myers JN; Mank-Seymour A; Zitvogel L; Storkus W; Clarke M; Johnson CS; Tahara H; Lotze MT
Laryngoscope; 1998 Feb; 108(2):261-8. PubMed ID: 9473079
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12.
Wong RJ; Chan MK; Yu Z; Ghossein RA; Ngai I; Adusumilli PS; Stiles BM; Shah JP; Singh B; Fong Y
Clin Cancer Res; 2004 Jul; 10(13):4509-16. PubMed ID: 15240543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
